Coronary Artery Disease (StatPearls CME)

The same comprehensive StatPearls reference on coronary artery disease, here framed as the continuing-education resource it is — a structured tour of the disease for clinicians and trainees.

Its value is breadth with practical anchors: CAD is the leading cause of death worldwide (~15.5 million Americans affected); smoking is the top modifiable risk factor; a calcium score of zero excludes obstructive disease in 98% of symptomatic patients; guideline-directed therapy pairs aspirin, a beta-blocker, a statin, and nitroglycerin; STEMI demands PCI within two hours. It also presses the clinically vital point that atypical presentations are common and dangerous when missed.

The practical takeaway is a working framework for recognizing, evaluating, and managing CAD across its spectrum.

We rate the evidence high for a reference work: peer-reviewed, regularly updated, guideline-aligned, with 55 citations. Its clinical significance is foundational rather than novel. (Note: this is the same underlying StatPearls article as the “StatPearls, 2024” entry — a duplicate pair in our library; keep one.)